254 related articles for article (PubMed ID: 22677643)
1. The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Liu X; Wang S; Kao AA; Long Q
Cornea; 2012 Nov; 31(11):1235-9. PubMed ID: 22677643
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial.
Chen J; Dong F; Chen W; Sun X; Deng Y; Hong J; Zhang M; Yang W; Liu Z; Xie L
Chin Med J (Engl); 2014; 127(13):2407-12. PubMed ID: 24985574
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease.
Huang JF; Yafawi R; Zhang M; McDowell M; Rittenhouse KD; Sace F; Liew SH; Cooper SR; Pickering EH
Ophthalmology; 2012 Jul; 119(7):e43-50. PubMed ID: 22607938
[TBL] [Abstract][Full Text] [Related]
5. [HLA-DR antigen expression on conjunctival epithelial cells in patients with dry eye].
Mrugacz M; Zywalewska N
Klin Oczna; 2005; 107(4-6):278-9. PubMed ID: 16118938
[TBL] [Abstract][Full Text] [Related]
6. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
[TBL] [Abstract][Full Text] [Related]
8. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
Mencucci R; Boccalini C; Caputo R; Favuzza E
J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
[TBL] [Abstract][Full Text] [Related]
9. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
10. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
11. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
Avunduk AM; Avunduk MC; Varnell ED; Kaufman HE
Am J Ophthalmol; 2003 Oct; 136(4):593-602. PubMed ID: 14516798
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops.
Macri A; Scanarotti C; Bassi AM; Giuffrida S; Sangalli G; Traverso CE; Iester M
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):425-30. PubMed ID: 25398660
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of HLA-DR antigen in conjunctival epithelial cells of patients with cystic fibrosis.
Mrugacz M; Zak J; Bakunowicz-Lazarczyk A; Wysocka J; Minarowska A
Eye (Lond); 2007 Aug; 21(8):1062-6. PubMed ID: 16710427
[TBL] [Abstract][Full Text] [Related]
14. OCT assessment of tear meniscus after punctal occlusion in dry eye disease.
Ibrahim OM; Dogru M; Kojima T; Matsumoto Y; Wakamatsu TH; Tsubota K; Fujishima H
Optom Vis Sci; 2012 May; 89(5):E770-6. PubMed ID: 22466101
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
16. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
19. Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models.
Versura P; Profazio V; Schiavi C; Campos EC
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5488-96. PubMed ID: 21498621
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
Li Z; Choi W; Oh HJ; Yoon KC
Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
